Form D · Other Health Care

Slate Bio, Inc.

Charlottesville, VA · CIK 0001862143

Offering snapshot reported May 25, 2023 · SEC filing

Reported sold
$2.78M
Offering amount: $3M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 30, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.39M$2.78MJan 17, 2023: $1,349,960.00Jan 17, 2023May 25, 2023: $2,776,949.00May 25, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,349,960 → $2,776,949
  • Reported investors6 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 25, 2023Amendment$2,776,949$1,426,989vs Jan 17, 20239SEC filing
Jan 17, 2023Initial$1,349,960No comparison6SEC filing
Jun 3, 2021Initial$1,999,956No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-470922

Source: Form D, filed May 25, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Creeden Director
Brian Gallagher Director
Andrew Krouse Director, Executive
Kyparissia Sirinakis Director
Kurt Woerpel Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
310 2 Nd Street Se, Suite B
Charlottesville, VA, 22902